Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

339 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction. Angiographic results from the PRISM-PLUS trial (Platelet receptor inhibition for ischemic syndrome management in patients limited by unstable signs and symptoms). PRISM-PLUS Investigators.
Zhao XQ, Théroux P, Snapinn SM, Sax FL. Zhao XQ, et al. Among authors: theroux p. Circulation. 1999 Oct 12;100(15):1609-15. doi: 10.1161/01.cir.100.15.1609. Circulation. 1999. PMID: 10517731 Clinical Trial.
Glycoprotein IIb/IIIa receptor blockade improves outcomes in diabetic patients presenting with unstable angina/non-ST-elevation myocardial infarction: results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) study.
Théroux P, Alexander J Jr, Pharand C, Barr E, Snapinn S, Ghannam AF, Sax FL. Théroux P, et al. Circulation. 2000 Nov 14;102(20):2466-72. doi: 10.1161/01.cir.102.20.2466. Circulation. 2000. PMID: 11076818 Clinical Trial.
Long-term use of ticagrelor in patients with prior myocardial infarction.
Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K, Bengtsson O, Oude Ophuis T, Budaj A, Theroux P, Ruda M, Hamm C, Goto S, Spinar J, Nicolau JC, Kiss RG, Murphy SA, Wiviott SD, Held P, Braunwald E, Sabatine MS; PEGASUS-TIMI 54 Steering Committee and Investigators. Bonaca MP, et al. Among authors: theroux p. N Engl J Med. 2015 May 7;372(19):1791-800. doi: 10.1056/NEJMoa1500857. Epub 2015 Mar 14. N Engl J Med. 2015. PMID: 25773268 Free article. Clinical Trial.
Redefining medical treatment in the management of unstable angina.
Braunwald E, Califf RM, Cannon CP, Fox KA, Fuster V, Gibler WB, Harrington RA, King SB 3rd, Kleiman NS, Theroux P, Topol EJ, Van de Werf F, White HD, Willerson JT. Braunwald E, et al. Among authors: theroux p. Am J Med. 2000 Jan;108(1):41-53. doi: 10.1016/s0002-9343(99)00416-7. Am J Med. 2000. PMID: 11059440 Review.
Oral glycoprotein IIb/IIIa antagonism in patients with coronary artery disease.
Catella-Lawson F, Kapoor S, Moretti D, De Marco S, Vigilante GJ, Cucchiara AJ, Ramsey KE, Combe S, Rocca B, Theroux P, FitzGerald GA; AFIRME Investigators. Antagonism of the Fibrinogen Receptor after Myocardial Events. Catella-Lawson F, et al. Among authors: theroux p. Am J Cardiol. 2001 Aug 1;88(3):236-42. doi: 10.1016/s0002-9149(01)01632-0. Am J Cardiol. 2001. PMID: 11472700 Clinical Trial.
339 results